Catalyst
Slingshot members are tracking this event:
ZIOPHARM (ZIOP) to launch Phase 1 clinical trial of off-the-shelf primary NK cells for investigational therapy of acute myeloid leukemia in 2016
Do you think this event is important to the companies below? How will it affect their stock price?
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 06, 2017
Occurred Source:
http://ir.ziopharm.com/releasedetail.cfm?ReleaseID=1047327
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Nk Therapy, Nk Cells, Acute Myeloid Leukemia, Phase 1
